scholarly journals Integrated privacy decision in BPMN clinical care pathways models using DMN

2022 ◽  
Vol 196 ◽  
pp. 509-516
Author(s):  
Intidhar Essefi ◽  
Hanene Boussi Rahmouni ◽  
Mohamed Fethi Ladeb
Keyword(s):  
Clinical Care ◽  
Care Pathways

scholarly journals Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance

2021 ◽  
Author(s):  
G. Hampson ◽  
M. Stone ◽  
J. R. Lindsay ◽  
R. K. Crowley ◽  
S. H. Ralston
Keyword(s):  
Clinical Care ◽  
Fragility Fractures ◽  
Osteoporosis Treatment ◽  
Healthcare Services ◽  
Urgent Care ◽  
Health Concern ◽  
Care Pathways ◽  
Long Term Conditions ◽  
Treatment Pathways ◽  
Diagnosis And Management

AbstractIt is acknowledged that the COVID-19 pandemic has caused profound disruption to the delivery of healthcare services globally. This has affected the management of many long-term conditions including osteoporosis as resources are diverted to cover urgent care. Osteoporosis is a public health concern worldwide and treatment is required for the prevention of further bone loss, deterioration of skeletal micro-architecture, and fragility fractures. This review provides information on how the COVID-19 pandemic has impacted the diagnosis and management of osteoporosis. We also provide clinical recommendations on the adaptation of care pathways based on experience from five referral centres to ensure that patients with osteoporosis are still treated and to reduce the risk of fractures both for the individual patient and on a societal basis. We address the use of the FRAX tool for risk stratification and initiation of osteoporosis treatment and discuss the potential adaptations to treatment pathways in view of limitations on the availability of DXA. We focus on the issues surrounding initiation and maintenance of treatment for patients on parenteral therapies such as zoledronate, denosumab, teriparatide, and romosozumab during the pandemic. The design of these innovative care pathways for the management of patients with osteoporosis may also provide a platform for future improvement to osteoporosis services when routine clinical care resumes.

scholarly journals Step by step development of clinical care pathways for older cancer patients: Necessary or desirable?

2007 ◽  
Vol 43 (15) ◽  
pp. 2170-2178 ◽  
Author(s):  
Maruscha de Vries ◽  
Julia C.M. van Weert ◽  
Jesse Jansen ◽  
Valery E.P.P. Lemmens ◽  
Huub A.A.M. Maas
Keyword(s):  
Cancer Patients ◽  
Clinical Care ◽  
Care Pathways ◽  
Older Cancer Patients

scholarly journals Clinical characteristics and care pathways of patients with personality disorder who died by suicide

BJPsych Open ◽  
2020 ◽  
Vol 6 (2) ◽  
Author(s):  
Sandra Flynn ◽  
Jane Graney ◽  
Thabiso Nyathi ◽  
Jessica Raphael ◽  
Seri Abraham ◽  
...  
Keyword(s):  
Personality Disorder ◽  
Clinical Care ◽  
Case Series ◽  
Drug Misuse ◽  
Care Pathways ◽  
Short Term ◽  
Psychological Therapies ◽  
Patient Admissions ◽  
History Of ◽  
The Uk

Background It is estimated that 1 in 10 people have a personality disorder. People with emotionally unstable personality disorder are at high risk of suicide. Despite being frequent users of mental health services, there is often no clear pathway for patients to access effective treatments. Aims To describe the characteristics of patients with personality disorder who died by suicide, examine clinical care pathways and explore whether the care adhered to National Institute for Health and Care Excellence guidance. Method National consecutive case series (1 January 2013 to 31 December 2013). The study examined the health records and serious incident reports of patients with personality disorder who died by suicide in the UK. Results The majority had a diagnosis of borderline/emotionally unstable or antisocial personality disorder. A high proportion of patients had a history of self-harm (n = 146, 95%) and alcohol (n = 101, 66%) or drug misuse (n = 79, 52%). We found an extensive pattern of service contact in the year before death, with no clear pathway for patients. Care was inconsistent and there were gaps in service provision. In 99 (70%) of the 141 patients with data, the last episode of care followed a crisis. Access to specialised psychological therapies was limited; short-term in-patient admissions was adhered to; however, guidance on short-term prescribing for comorbid conditions was not followed for two-thirds of patients. Conclusions Continuity and stability of care is required to prevent, rather than respond to individuals in crisis. A comprehensive audit of services for people with personality disorder across the UK is recommended to assess the quality of care provided.

Effect of Clinical Care Pathways on Quality of Life and Physical Function After Fragility Fracture: A Meta-analysis

2019 ◽  
Vol 20 (7) ◽  
pp. 926.e1-926.e11 ◽  
Author(s):  
Jason Talevski ◽  
Kerrie M. Sanders ◽  
Gustavo Duque ◽  
Catherine Connaughton ◽  
Alison Beauchamp ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Physical Function ◽  
Fragility Fracture ◽  
Meta Analysis ◽  
Clinical Care ◽  
Care Pathways

scholarly journals P083 Designing online HIV information, testing and clinical care pathways to address users’ expectations and emotions

2019 ◽  
Author(s):  
Jo Gibbs ◽  
Aneesha Singh ◽  
Claudia Estcourt ◽  
Pam Sonnenberg ◽  
Ann Blandford
Keyword(s):  
Clinical Care ◽  
Care Pathways

scholarly journals Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment

2016 ◽  
Vol 3 (1) ◽  
Author(s):  
Nik Howes ◽  
Sam Lattimore ◽  
William Lucien Irving ◽  
Brian James Thomson
Keyword(s):  
Hepatitis C ◽  
Primary Care Physicians ◽  
Substance Misuse ◽  
Clinical Care ◽  
Hcv Infection ◽  
Hcv Rna ◽  
Care Pathways ◽  
Major Barrier ◽  
Baseline Study ◽  
New Diagnosis

Abstract Background.  Engagement of individuals infected with hepatitis C virus (HCV) with care pathways remains a major barrier to realizing the benefits of new and more effective antiviral therapies. After an exploratory study, we have undertaken an evidence-based redesign of care pathways for HCV, including the following: (1) reflex testing of anti-HCV-positive samples for HCV RNA; (2) annotation of laboratory results to recommend referral of actively infected patients to specialist clinics; (3) educational programs for primary care physicians and nurses; and (4) the establishment of needs-driven community clinics in substance misuse services. Methods.  In this study, we conducted a retrospective cohort study of progression through care pathways of individuals with a new diagnosis of HCV infection made between January 2010 and January 2012. We also analyzed patient flow through new care pathways and compared this with our baseline study of identical design. Results.  A total of 28 980 samples were tested for anti-HCV antibody during the study period and yielded 273 unique patients with a new diagnosis of HCV infection. Of these, 38% were tested in general practice, 21% were tested in substance misuse services, 23% were tested in secondary care, and 18% were tested in local prisons. Overall, 80% of patients were referred to specialist clinics, 70% attended for assessment, and 38% commenced treatment, in comparison to 49%, 27%, and 10%, respectively, in the baseline study. Referral rates from all testing sources improved. Conclusions.  This study provides timely evidence that progression through care pathways can be enhanced, and it demonstrates reduction of key barriers to eradication of HCV.

scholarly journals Next-Generation Allergic Rhinitis Care in Singapore: 2019 ARIA Care Pathways

2020 ◽  
Vol 49 (11) ◽  
pp. 885-896
Author(s):  
Xuandao Liu ◽  
De Yun Wang ◽  
Tze Choong Charn ◽  
Leslie Timothy Koh ◽  
Neville WY Teo ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Clinical Care ◽  
Work Productivity ◽  
Suboptimal Control ◽  
Current Status ◽  
Local Context ◽  
Care Pathways ◽  
Important Health ◽  
Integrated Care Pathways ◽  
Important Health Issue

Allergic rhinitis (AR) is prevalent in Singapore, with a significant disease burden. Afflicting up to 13% of the population, AR impairs quality of life, leads to reduced work productivity and is an independent risk factor for asthma. In the last 2 decades, local studies have identified patient and physician behaviours leading to suboptimal control of the disease. Yet, there is an overall lack of attention to address this important health issue. Allergic Rhinitis and its Impact on Asthma (ARIA) is a European organisation aimed at implementing evidence-based management for AR worldwide. Recent focus in Europe has been directed towards empowering patients for self-management, exploring the complementary role of mobile health, and establishing healthcare system-based integrated care pathways. Consolidation of these ongoing efforts has led to the release of the 2019 ARIA care pathways. This review summarises the ARIA update with particular emphasis on the current status of adult AR in Singapore. In addition, we identify unmet needs and future opportunities for research and clinical care of AR in the local context. Keywords: Allergen immunotherapy, Allergic Rhinitis and its Impact on Asthma, clinical guideline

scholarly journals Home respiratory rehabilitation: a purposes literature review focusing on the clinical pathway management

2020 ◽  
Author(s):  
Civitillo Claudio ◽  
Romano Angelo ◽  
Di Lorenzo Luigi
Keyword(s):  
Clinical Pathways ◽  
Clinical Care ◽  
Care Program ◽  
Care Pathways ◽  
Critical Pathways ◽  
Management Plans ◽  
Integrated Care Pathways ◽  
Care Maps ◽  
Respiratory Rehabilitation

Clinical Care pathways, also known as critical pathways, integrated care pathways, case management plans, clinical care pathways or care maps, are used to systematically plan and follow up a patient focused care program. Clinical pathways are used all over the world and so for respiratory rehabilitation pathways (RR) and the importance of knowledge and learning Evidence Based Practice (EBP) is well known and mandatory. However, the EBP acquisitions of the home RR model and the knowledge of Clinical Care Pathways (PCA) are poorly defined.

Sign in / Sign up

Export Citation Format

Share Document